[1]CollectionofCzechoslovakChemicalCommunications,2002,vol.67,#11,p.1669-1680
[1]TetrahedronLetters,2009,vol.50,#50,p.7035-7037
[2]BioorganicandMedicinalChemistry,2006,vol.14,#14,p.4958-4979
[3]Patent:WO2010/132615,2010,A1,.Locationinpatent:Page/Pagecolumn100-101
[4]BioorganicandMedicinalChemistryLetters,2009,vol.19,#24,p.6926-6930
[5]Patent:WO2011/56630,2011,A2,.Locationinpatent:Page/Pagecolumn64-65
[6]CollectionofCzechoslovakChemicalCommunications,2002,vol.67,#11,p.1669-1680
[7]OrganicLetters,2015,vol.17,#11,p.2652-2655
[8]Patent:EP3299371,2018,A1,.Locationinpatent:Paragraph0314;0315
[9]Farmaco,2001,vol.56,#11,p.835-840
[10]TetrahedronAsymmetry,2006,vol.17,#4,p.521-535
[11]Patent:US2009/247573,2009,A1,.Locationinpatent:Page/Pagecolumn26-27
[12]Patent:US6352988,2002,B2,.Locationinpatent:Pagecolumn33-34
[13]Chemistry-AEuropeanJournal,2014,vol.20,#24,p.7492-7500
[14]Patent:WO2015/31608,2015,A1,.Locationinpatent:Paragraph00351
[15]JournalofChemicalResearch,2015,vol.39,#5,p.296-299
[1]Patent:EP1124810,2005,B1,.Locationinpatent:Page/Pagecolumn12
[2]Patent:US5464861,1995,A,
[1]JournalofMedicinalChemistry,2007,vol.50,#8,p.1939-1957
[2]Patent:US5877199,1999,A,
[3]Patent:WO2008/72784,2008,A1,.Locationinpatent:Page/Pagecolumn109
[1]JournalofHeterocyclicChemistry,2011,vol.48,#4,p.977-986
[2]JournaloftheIranianChemicalSociety,2012,vol.9,#5,p.655-660
[3]ChineseJournalofChemistry,2010,vol.28,#12,p.2399-2403
[4]TetrahedronLetters,1988,vol.29,#21,p.2577-2580
[5]TetrahedronLetters,2003,vol.44,#27,p.5115-5119
[1]TetrahedronAsymmetry,2006,vol.17,p.521-535
[1]Patent:US2005/288354,2005,A1
[1]JournalofMedicinalChemistry,2007,vol.50,p.1939-1957
[2]Patent:US5877199,1999,A
[3]Patent:WO2008/72784,2008,A1.Locationinpatent:Page/Pagecolumn109
[1]JournalofChemicalResearch,2015,vol.39,p.296-299
[2]JournalofMedicinalChemistry,2007,vol.50,p.1939-1957
[1]ChemicalandPharmaceuticalBulletin,2007,vol.55,p.922-925
Title: Methyl 3-(1H-indol-3-yl)propano-ate.
Journal: Acta crystallographica. Section E, Structure reports online 20110801
Title: Isosteric probes provide structural requirements essential for detoxification of the phytoalexin brassinin by the fungal pathogen Leptosphaeria maculans.
Journal: Bioorganic & medicinal chemistry 20070915